Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Abstract
No abstract available
Funding Information
  • Danish Agency for Science, Technology and Innovation and the Danish Council for Strategic Research (EDITORS, grant 09-066994)

This publication has 27 references indexed in Scilit: